Related Experiment Video
Updated: Apr 4, 2026
A Mouse Model of Chronic Liver Fibrosis for the Study of Biliary Atresia
Published on: February 3, 2023
MicroRNAs in the Cholangiopathies: Pathogenesis, Diagnosis, and Treatment
Maria Jose Lorenzo Pisarello1, Lorena Loarca2, Tommy Ivanics3
1Division of Gastroenterology and Hepatology, and the Mayo Clinic Center for Signaling in Gastroenterology, Mayo Clinic, Rochester, MN 55905, USA. Pisarello.maria@mayo.edu.
Abstract:
The cholangiopathies are a group of liver diseases resulting from different etiologies but with the cholangiocyte as the primary target. As a group, the cholangiopathies result in significant morbidity and mortality and represent one of the main indications for liver transplant in both children and adults. Contributing to this situation is the absence of a thorough understanding of their pathogenesis and a lack of adequate diagnostic and prognostic biomarkers. MicroRNAs are small non-coding RNAs that modify gene expression post-transcriptionally. They have been implicated in the pathogenesis of many diseases, including the cholangiopathies. Thus, in this review we provide an overview of the literature on miRNAs in the cholangiopathies and discuss future research directions.
Insights
Cholangiopathies, liver diseases targeting cholangiocytes, cause significant health issues. MicroRNAs (miRNAs) are involved in their development, offering potential diagnostic and therapeutic targets for these complex liver conditions.
Area of Science:
- Hepatology and molecular biology, focusing on liver diseases and gene regulation.
Background:
- Cholangiopathies are a diverse group of liver diseases primarily affecting cholangiocytes.
- These conditions lead to substantial morbidity and mortality, frequently necessitating liver transplantation.
- Current understanding of cholangiopathy pathogenesis and lack of biomarkers hinder effective management.
Purpose of the Study:
- To review the current literature on the role of microRNAs (miRNAs) in cholangiopathies.
- To explore miRNAs as potential diagnostic and prognostic biomarkers for these liver diseases.
- To identify future research directions in miRNA-based therapeutic strategies for cholangiopathies.
Main Methods:
- Comprehensive literature review of studies investigating microRNAs in cholangiopathies.
- Analysis of existing research on miRNA involvement in the pathogenesis of liver diseases affecting cholangiocytes.
- Discussion of potential applications of miRNAs in clinical diagnostics and therapeutics for cholangiopathies.
Main Results:
- MicroRNAs (small non-coding RNAs) play a significant role in post-transcriptional gene regulation.
- Evidence implicates miRNAs in the pathogenesis of various cholangiopathies.
- miRNAs represent promising candidates for novel diagnostic and prognostic biomarkers.
Conclusions:
- MicroRNAs are critically involved in the molecular mechanisms underlying cholangiopathies.
- Further research into miRNAs could lead to improved diagnostic tools and targeted therapies for liver diseases.
- Understanding miRNA functions is essential for advancing the management of cholangiopathies.
Related Concept Videos
01:29Chronic Pancreatitis II: Collaborative Care
Assessment:
01:17Chronic Bowel Disorders: Introduction
Irritable Bowel Syndrome (IBS) is a common disorder affecting the gastrointestinal tract. The distinctive feature is recurrent abdominal pain associated with altered bowel movements, manifesting as constipation, diarrhea, or fluctuating between both. The...
01:24Chronic Pancreatitis I: Introduction
Pancreatitis is the inflammation of the pancreas, which occurs when the immune system becomes active and causes swelling, pain, and disruptions in organ function. Pancreatitis can manifest as either an acute or chronic condition.
Acute pancreatitis arises suddenly and lasts for a brief duration, while chronic pancreatitis is a long-term affliction...
01:24Microbial Corrosion
01:22MicroRNAs